Resumen

TORRES-ESCOBAR, Gabriela et al. Impact of COVID-19 on reperfusion strategies for acute coronary syndromes. Arch. Cardiol. Méx. [online]. 2020, vol.90, suppl.1, pp.62-66.  Epub 24-Mar-2021. ISSN 1665-1731.  https://doi.org/10.24875/acm.m20000069.

Reperfusion therapy is a measure of care in patients with ST-elevation myocardial infarction (STEMI), which should be performed once we have the diagnosis. Percutaneous coronary intervention is considered the gold standard, however in patients with SARS-CoV-2 infection, the reperfusion strategy is more focused on fibrinolytic therapy due to the shorter time required to perform and less exposure. This pandemic represents a contact problem in health personnel, since cases are increasing worldwide, so it is important to know the measures that must be followed to avoid coronavirus disease (COVID-19).

Palabras llave : COVID-19; Pandemic; Fibrinolysis; Angioplasty; STEMI; NSTEMI.